{"id":"W2121607722","doi":"10.1093/annonc/mdj965","title":"Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":116,"is_retracted":true,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Eli Lilly and Company","keywords":"Medicine; Vinblastine; Gemcitabine; Internal medicine; Oncology; Hazard ratio; Bladder cancer; Cisplatin; Transitional cell carcinoma; Progression-free survival; Chemotherapy; Urology; Confidence interval; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Duplication of/in Article;","date":"11/1/2011 0:00","openalex_flagged":true},"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003558464,0.001622544,0.004237831,0.0004235972,0.0007742872,0.001537561,0.00135383,0.002882096,0.005494543],"category_scores_gemma":[0.004381068,0.0009920222,0.00482916,0.000578208,0.001664159,0.00197584,0.0007777869,0.005330923,0.0009370562],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001685796,"about_ca_system_score_gemma":0.001469999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001566261,"about_ca_topic_score_gemma":0.003117817,"domain_scores_codex":[0.9977812,0.001350792,0.0001915181,0.0003551198,0.00008839562,0.0002329641],"domain_scores_gemma":[0.9959893,0.00156426,0.0008793241,0.0003577228,0.0001811878,0.001028262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.992998,0.001446778,0.0006841071,0.0001334541,0.001222332,0.00001512636,0.00001854424,0.0002073861,0.0004960696,0.0000213673,0.0001124679,0.002644283],"study_design_scores_gemma":[0.9414511,0.05240924,0.002796129,0.00003421481,0.002398431,0.00002688057,0.00002735992,0.0002779321,0.0002324401,0.0000914982,0.0002388537,0.00001595169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908591,0.005239409,0.0003474335,0.000863753,0.0005132276,0.0007131018,0.000548726,0.00003808958,0.0008771046],"genre_scores_gemma":[0.9947093,0.00138644,0.000521908,0.0006948683,0.000354469,0.0005808858,0.0007844097,0.00001813702,0.0009497144],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005494543,"threshold_uncertainty_score":0.01881915,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04530653708582257,"score_gpt":0.3610820792918614,"score_spread":0.3157755422060388,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}